Human PRKACa ELISA Kit Drug Target Proteins Do not mix components of

Do not mix components of the kit from different batches (except for wash buffer and reaction stop solution)

Patients with metastatic colorectal cancer that expresses EGFR may be treated with cetuximab in combination with chemotherapy or cetuximab may be given as a single therapy to patients who have failed to respond to irinotecan- and oxaliplatin-based regimens

the whole VEGF165 structure has not been determined

and HRP enzyme conjugate are sequentially added to microwells pre-coated with a Procollagen I (PCI) capture antibody

Human PRKACa ELISA Kit Drug Target Proteins Do not mix components ofProduct Specification Usage Required experimental equipment: 1. Microplate reader (450nm) 2. High precision pipettes and pipette tips: 0. 5 10uL, 5 50uL, 20 200uL, 200 1000uL 3. 37C incubator 4. Distilled or deionized water Sample preparation and requirements: Tissue homogenization: Rinse the tissue with pre chilled PBS (0. 01M, pH 7. 4) to remove residual blood (lysed red blood cells in the homogenate will affect the measurement results). Weigh and